secwatch.observer — SEC 8-K summary
======================================

Issuer:     BullFrog AI Holdings, Inc. (BFRG)
CIK:        0001829247
Form:       8-K
Filed at:   2023-12-29T23:59:59+00:00
Accession:  0001493152-23-046489
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bullfrog AI highlights 2023 achievements: $8.4M IPO, first revenue, key partnerships
--------------------------------------------------------------------------------

- Completed $8.4M IPO listing on Nasdaq in 2023; maintained low burn rate quarter to quarter.
- Recorded first earned revenue in Q3 2023; transition to commercial operations.
- Entered exclusive partnership with Lieber Institute for Brain Development for neuropsychiatric drug discovery.
- Demonstrated efficacy of oncology drug candidates BF-223 and BF-222 in glioblastoma animal model; patent issued for BF-223.
- Identified three novel colorectal cancer targets via JCVI partnership; market $11.5B in 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1829247/000149315223046489/0001493152-23-046489-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1829247/000149315223046489/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-046489

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer